Supplementary data: Manitoba

This page provides data visualizations related to the priorities for Canada’s cancer system.

The data tables and technical appendix for all indicators are available upon request at info@partnershipagainstcancer.ca.

Priority 1 Action 1: Help people to stop smoking or not start in the first place and live healthier lives

Topic: Keeping people smoke-free
Title of image: Percentage of individuals (aged ≥ 12) classified as daily or occasional smokers
Caveats/limitations:

  • This indicator was reported using the Canadian Community Health Survey (CCHS).
  • Individuals who did not respond to the required CCHS questions regarding smoking status were not included in the analysis.
  • The COVID-19 pandemic had major impacts on the data collection operations and response rates for this survey.

Manitoba: 15.4% in 2020, and 11.1% in 2021. Canada: 12.9% in 2020, and 11.8% in 2021.
Data source: Canadian Community Health Survey

Topic: Keeping people smoke-free
Title of image: Percentage of males (aged ≥ 18) classified as daily or occasional smokers, by household income quintile
Caveats/limitations:

  • The COVID-19 pandemic had major impacts on the data collection operations and response rates for this survey.
  • Interpret with caution owing to large variability in the 2021 estimates.

Quintile 1: 33.7% in 2019, and 21.5% in 2021. Quintile 2: 20.6% in 2019, and 8.1% in 2021. Quintile 3: 11.3% in 2019, and 15.2% in 2021. Quintile 4: 18.4% in 2019, and 8.9% in 2021. Quintile 5: 14.5% in 2019, and 6.5% in 2021.

Data source: Canadian Community Health Survey

Topic: Keeping people smoke-free
Title of image: Percentage of females (aged ≥ 18) classified as daily or occasional smokers, by household income quintile
Caveats/limitations:

  • The COVID-19 pandemic had major impacts on the data collection operations and response rates for this survey.
  • Interpret with caution owing to large variability in the 2021 estimates.

Quintile 1: 16.4% in 2019, and 16.3% in 2021. Quintile 2: 12.3% in 2019, and 11.1% in 2021. Quintile 3: 11.3% in 2019, and 8.1% in 2021. Quintile 4: 7% in 2019, and 11.4% in 2021. Quintile 5: 14.9% in 2019, and 11.3% in 2021.

Data source: Canadian Community Health Survey

Topic: Keeping people smoke-free
Title of image: Percentage of males (aged ≥ 18) classified as daily or occasional smokers, by education
Caveats/limitations:

  • The COVID-19 pandemic had major impacts on the data collection operations and response rates for this survey.
  • Interpret with caution owing to large variability in the 2021 estimates.

Less than Secondary school graduation was 29.4% in 2019 and 23.1% in 2021 Secondary school graduation, no post-secondary education was 26.7% in 2019 and 12% in 2021 Post-secondary certificate/diploma or university degree was 12.6% in 2019 and 10.4% in 2021Data source: Canadian Community Health Survey

Topic: Keeping people smoke-free
Title of image: Percentage of females (aged ≥ 18) classified as daily or occasional smokers, by education
Caveats/limitations:

  • The COVID-19 pandemic had major impacts on the data collection operations and response rates for this survey.
  • Interpret with caution owing to large variability in the 2021 estimates.

Less than Secondary school graduation was 24.2% in 2019 and 20.6% in 2021 Secondary school graduation, no post-secondary education was 15.1% in 2019 and 15.1% in 2021 Post-secondary certificate/diploma or university degree was 8.8% in 2019 and 8.7% in 2021

Data source: Canadian Community Health Survey


Topic: Maintaining healthy body weight
Title of image: Percentage of individuals (aged ≥ 18) classified as overweight or obese
Caveats/limitations:

  • This indicator was reported using the Canadian Community Health Survey (CCHS).
  • Individuals who did not respond to the required CCHS questions to derive the BMI classifications were not included in the analysis.
  • The COVID-19 pandemic had major impacts on the data collection operations and response rates for this survey.

MB: 67.6% in 2019, and 68% in 2021 Canada: 65.9% in 2019, and 64.7% in 2021.
Data source: Canadian Community Health Survey

Topic: Maintaining healthy body weight
Title of image: Percentage of males (aged ≥ 18) classified as overweight or obese, by income quintile
Caveats/limitations: The COVID-19 pandemic had major impacts on the data collection operations and response rates for this survey.

Quintile 1: 61.7% in 2019, and 72.4% in 2021. Quintile 2: 71.6% in 2019, and 70.8% in 2021. Quintile 3: 71.7% in 2019, and 73.3% in 2021. Quintile 4: 81% in 2019, and 74.6% in 2021. Quintile 5: 78.1% in 2019, and 75.1% in 2021.
Data source: Provincial cancer agencies and programs

Topic: Maintaining healthy body weight
Title of image: Percentage of females (aged ≥ 18) classified as overweight or obese, by income quintile
Caveats/limitations: The COVID-19 pandemic had major impacts on the data collection operations and response rates for this survey.

Quintile 1: 60.8% in 2019, and 61.5% in 2021. Quintile 2: 63.6% in 2019, and 62.8% in 2021. Quintile 3: 60.8% in 2019, and 67.6% in 2021. Quintile 4: 64.5% in 2019, and 63.5% in 2021. Quintile 5: 60.9% in 2019, and 58% in 2021.Data source: Provincial cancer agencies and programs

Topic: Maintaining healthy body weight
Title of image: Percentage of individuals (aged ≥ 18) classified as overweight or obese, by sex
Caveats/limitations: The COVID-19 pandemic had major impacts on the data collection operations and response rates for this survey.

Male: 72.9% in 2017-2018, and 73.1% in 2021. Female: 62.2% in 2017-2018, and 62.8% in 2021.
Data source: Canadian Community Health Survey

Priority 1 Action 2: Adopt proven practices known to reduce the risk of cancer

Topic: Increasing HPV vaccination
Title of image: Percentage of individuals who received a full course of HPV vaccination by age 13 through Manitoba’s routine immunization program, by sex
Caveats/limitations: The COVID-19 pandemic may have affected service provision.
2020: 62.8% for males, and 64.3% for females. 2021: 57.3% for males, and 58.5% for females.
Data source: Provincial cancer agencies and programs

Topic: Increasing HPV vaccination
Title of image: Percentage of males who received a full course of HPV vaccination by age 13 through Manitoba’s routine immunization program, by Regional Health Authority
Caveats/limitations: The COVID-19 pandemic may have affected service provision.
Winnipeg Regional Health Authority: 67.8% in 2020, and 62.4% in 2021. Southern Health: 51.6% in 2020, and 44.1% in 2021. Interlake Eastern Regional Health Authority: 65% in 2020, and 58.3% in 2021. Prairie Mountain Health: 65.1% in 2020, and 67.3% in 2021. Northern Regional Health Authority: 49.8% in 2020, and 39.6% in 2021.
Data source: Provincial cancer agencies and programs

Topic: Increasing HPV vaccination
Title of image: Percentage of females who received a full course of HPV vaccination by age 13 through Manitoba’s routine immunization program, by Regional Health Authority
Caveats/limitations: The COVID-19 pandemic may have affected service provision.
Winnipeg Regional Health Authority: 69.8% in 2020, and 64% in 2021. Southern Health: 50.3% in 2020, and 47.1% in 2021. Interlake Eastern Regional Health Authority: 66.8% in 2020, and 60.3% in 2021. Prairie Mountain Health: 67.6% in 2020, and 66.8% in 2021. Northern Regional Health Authority: 54.2% in 2020, and 38.8% in 2021.
Data source: Provincial cancer agencies and programs

Topic: Increasing HPV vaccination
Title of image: Percentage of females who received a full course of HPV vaccination by age 17 through Manitoba’s routine immunization program
Caveats/limitations: The COVID-19 pandemic may have affected service provision.
61.3% in 2020, and 72.6% in 2021.

Data source: Provincial cancer agencies and programs

Topic: Increasing HPV vaccination
Title of image: Percentage of females who received a full course of HPV vaccination by age 17 through Manitoba’s routine immunization program, by Regional Health Authority
Caveats/limitations: The COVID-19 pandemic may have affected service provision.
Winnipeg Regional Health Authority: 65.5% in 2020, and 77.2% in 2021. Southern Health: 46.7% in 2020, and 57.5% in 2021. Interlake Eastern Regional Health Authority: 64.5% in 2020, and 71.6% in 2021. Prairie Mountain Health: 64.2% in 2020, and 76.5% in 2021. Northern Regional Health Authority: 58.4% in 2020, and 69.3% in 2021.
Data source: Provincial cancer agencies and programs

Topic: Increasing genetic testing
Title of image: Percentage of breast/ovarian and colon cancer patients who were eligible and received a hereditary cancer screen (10- or 12-gene panel).
Caveats/limitations:

  • The COVID-19 pandemic may have affected service provision.
  • Eligibility for hereditary cancer screens include patients with no known pathogenic familial variant and who meet panel testing criteria. Individuals who do not meet this eligibility criteria include those with a familial mutation who will receive genetic testing for the mutation of interest only or those who do not meet full criteria for the 10- or 12-gene panel but may have other genetic testing panels completed (e.g., individuals meeting specific ethnic requirements for variants common in that population).

Breast and Ovarian cancer genetic testing in 2019 was 4.3% and 4.6% in 2020 Colon cancer genetic testing in 2019 was 1.1% and 1.3% in 2020

Data source: Provincial cancer agencies and programs

Topic: Increasing genetic testing
Title of image: Percentage of breast/ovarian cancer patients who were eligible and received hereditary cancer screening (10- or 12-gene panel), by age group
Caveats/limitations:

  • The COVID-19 pandemic may have affected service provision.
  • Eligibility for hereditary cancer screens include patients with no known pathogenic familial variant and who meet panel testing criteria. Individuals who do not meet this eligibility criteria include those with a familial mutation who will receive genetic testing for the mutation of interest only or those who do not meet full criteria for the 10- or 12-gene panel but may have other genetic testing panels completed (e.g., individuals meeting specific ethnic requirements for variants common in that population).

In 2019: 20 to 40 years was 22.2%. 41 to 60 years was 5.2%. 61 to 70 years was 2.2%. 71 and above was 3%. In 2021: 20 to 40 years was 34.9%. 41 to 60 years was 3.9%. 61 to 70 years was 2.8%. 71 and above was 1.2%.

Data source: Provincial cancer agencies and programs

Topic: Increasing genetic testing
Title of image: Percentage of colorectal cancer patients diagnosed within a two-year period who had a completed tumour tissue screen for Lynch Syndrome (MMR testing)
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

53.6% in 2018-2019 56.6% in 2019-2020

Data source: Provincial cancer agencies and programs

Topic: Increasing genetic testing
Title of image: Percentage of colorectal cancer patients diagnosed within a two-year period who had a completed tumour tissue screen for Lynch Syndrome (MMR testing) , by age group
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

Under 70 years was 81.6% in 2018 to 2019 and 83% in 2019 to 2020 70 years and older was 25.9% in 2018 to 2019 and 31% in 2019 to 2020
Data source: Provincial cancer agencies and programs

Topic: Increasing genetic testing
Title of image: Percentage of colorectal cancer patients diagnosed within a two-year period who had a completed tumour tissue screen for Lynch Syndrome (MMR testing) , by sex
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

Male: 57.1% in 2018-2019 and 60.8% in 2019-2020 Female: 49.5% in 2018-2019 and 51.5% in 2019-2020

Data source: Provincial cancer agencies and programs

Priority 2 Action 1: Prioritize rapid access to appropriate diagnosis for those suspected of having cancer

Topic: Reducing wait for diagnosis
Title of image: Wait time from date of an abnormal CancerCare Manitoba BreastCheck screening result to date of final diagnosis when tissue biopsy is and is not required in females aged 50-74 in 2019-20.
Caveats/limitations: The COVID-19 pandemic may have affected service provision.
Tissue: Median is 5 weeks, 90th percentile is 12.4 weeks. Without tissue: Median is 2 weeks, 90th percentile is 5 weeks.

Data source: Provincial cancer agencies and programs

Topic: Reducing wait for diagnosis
Title of image: Wait time from the date of an abnormal BreastCheck screening mammogram result to the date of final diagnosis with tissue biopsy for females aged 50-74 in 2019-20, by Regional Health Authority
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

Winnipeg Regional Health Authority: Median is 5.4 weeks, 90th percentile is 13.1 weeks. Prairie Mountain Health: Median is 3.3 weeks, 90th percentile is 13.3 weeks. Interlake Eastern Regional Health Authority: Median is 4.9 weeks, 90th percentile is 13 weeks. Southern Health: Median is 4.4 weeks, 90th percentile is 9.9 weeks. Northern Regional Health Authority: Median is 6.1 weeks, 90th percentile is 12.1 weeks.

Data source: Provincial cancer agencies and programs

Topic: Reducing wait for diagnosis
Title of image: Wait time from the date of an abnormal CancerCare Manitoba BreastCheck screening mammogram result to the date of final diagnosis without tissue biopsy for females aged 50-74 in 2019-20, by Regional Health Authority
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

Winnipeg Regional Health Authority: Median is 2 weeks, 90th percentile is 5.1 weeks. Prairie Mountain Health: Median is 1.9 weeks, 90th percentile is 3.9 weeks. Interlake Eastern Regional Health Authority: Median is 2 weeks, 90th percentile is 5.9 weeks. Southern Health: Median is 1.9 weeks, 90th percentile is 4.6 weeks. Northern Regional Health Authority: Median is 2.6 weeks, 90th percentile is 7.9 weeks.

Data source: Provincial cancer agencies and programs

Topic: Diagnosing cancer earlier
Title of image: Proportion of late-stage diagnoses (stage IV) for lung, colorectal, bladder, and melanoma cancers, by sex
Caveats/limitations:

  • Duplicate/multiple instances of the same patient have been removed if they occur within the same cancer site.
  • If the same patient has more than one cancer across the four sites (lung, melanoma, bladder or colorectal), they were not removed.
  • The COVID-19 pandemic may have affected service provision.

For lung cancer in 2019: Males 50.1%. Females 44%. For lung cancer in 2020: Males 54.8%. Female 44.8%. For colorectal cancer in 2019: Males 24%. Females 19.9%. For colorectal cancer in 2020: Males 20.8%. Females 20.2%. For bladder cancer in 2019: Males 3.3%. Females 9.3%. For bladder cancer in 2020: Males 6.7%. Females 8.9%. For melanoma cancer in 2019: Males 1.8%. Females 0.5%. For melanoma cancer in 2020: Males 1.5%. Females 2.1%.

Data source: Provincial cancer agencies and programs

Topic: Diagnosing cancer earlier
Title of image: Stage distribution at time of lung cancer diagnosis
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

In 2019: Stage 0 or 1: 21.3%. Stage 2: 6.3%. Stage 3: 18.6%. Stage 4: 47%. Stage unknown or occult: 6.9%. In 2020: Stage 0 or 1: 24.3%. Stage 2: 7%. Stage 3: 14.2%. Stage 4: 49.8%. Stage unknown or occult: 4.7%.Data source: Provincial cancer agencies and programs

Topic: Diagnosing cancer earlier
Title of image: Stage distribution at time of colorectal cancer diagnosis
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

In 2019: Stage 0 or 1: 15.5%. Stage 2: 26.2%. Stage 3: 24.7%. Stage 4: 22.1%. Stage unknown or occult: 9.5%. In 2020: Stage 0 or 1: 15.2%. Stage 2: 25.6%. Stage 3: 28.2%. Stage 4: 20.5%. Stage unknown or occult: 10.4%.

Data source: Provincial cancer agencies and programs

Topic: Diagnosing cancer earlier
Title of image: Stage distribution at time of bladder cancer diagnosis
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

In 2019: Stage 0: 59.8% Stage 1: 19%. Stage 2: 8.4%. Stage 3: 4.5%. Stage 4: 4.7%. Stage unknown or occult: 3.6%. In 2020: Stage 0: 59.1% Stage 1: 16.7%. Stage 2: 8.4%. Stage 3: 4.9%. Stage 4: 7.2%. Stage unknown or occult: 3.7%.Data source: Provincial cancer agencies and programs

Topic: Diagnosing cancer earlier
Title of image: Stage distribution at time of melanoma (skin cancer) diagnosis
Caveats/limitations: The COVID-19 pandemic may have affected service provision.
In 2019: Stage 0: 43% Stage 1: 40.7%. Stage 2: 6%. Stage 3: 6%. Stage 4: 1.2%. Stage unknown or occult: 2.6%. In 2020: Stage 0: 43% Stage 1: 44.1%. Stage 2: 5.9%. Stage 3: 4.4%. Stage 4: 1.8%. Stage unknown or occult: 0.9%.

Data source: Provincial cancer agencies and programs

Priority 2 Action 2: Strengthen existing screening efforts and implement lung cancer screening programs across the country

Topic: Increasing participation in colorectal cancer screening
Title of image: Percentage of individuals aged 50-74 who are up to date on colon cancer screening.
Caveats/limitations:

  • Up to date for screening describes individuals 50-74 years of age who have completed a fecal test in the past two years and/or colonoscopy/sigmoidoscopy in the last five years.
  • The COVID-19 pandemic may have affected service provision.

50.2% in 2018-19, and 47% in 2019-20.

Data source: Provincial cancer agencies and programs

Topic: Increasing participation in colorectal cancer screening
Title of image: Percentage of individuals aged 50-74 who are up to date on colon cancer screening, by sex
Caveats/limitations:

  • Up to date for screening describes individuals 50-74 years of age who have completed a fecal test in the past two years and/or colonoscopy/sigmoidoscopy in the last five years.
  • The COVID-19 pandemic may have affected service provision.

Male: 47.7% in 2018-19, and 44.8% in 2019-20. Female: 52.7% in 2018-19, and 49.1% in 2020.

Data source: Provincial cancer agencies and programs

Topic: Increasing participation in colorectal cancer screening
Title of image: Percentage of individuals aged 50-74 who are up to date on colon cancer screening, by age group
Caveats/limitations:

  • Up to date for screening describes individuals 50-74 years of age who have completed a fecal test in the past two years and/or colonoscopy/sigmoidoscopy in the last five years
  • The COVID-19 pandemic may have affected service provision.

Age 50 to 54: 45.4% in 2018-19, and 39.3% in 2019-20. Age 55 to 59: 44.5% in 2018-19, and 41.3% in 2019-20. Age 60 to 64: 50.6% in 2018-19, and 47.6% in 2019-20. Age 65 to 69: 56% in 2018-19, and 53.7% in 2019-20. Age 70 to 74: 59.6% in 2018-19, and 59% in 2019-20.

Data source: Provincial cancer agencies and programs

Topic: Increasing participation in colorectal cancer screening
Title of image: Percentage of individuals aged 50-74 who are up to date on colon cancer screening, by Regional Health Authority.
Caveats/limitations:

  • Up to date for screening describes individuals 50-74 years of age who completed a fecal test in the past two years and/or colonoscopy/sigmoidoscopy in the last five years.
  • The COVID-19 pandemic may have affected service provision.

Winnipeg Regional Health Authority: 50.4% in 2020, and 47.2% in 2021. Prairie Mountain Health: 51.5% in 2020, and 48.1% in 2021. Interlake Eastern Regional Health Authority: 52% in 2020, and 48.7% in 2021. Southern Health: 48.6% in 2020, and 45.3% in 2021. Northern Regional Health Authority: 36.6% in 2020, and 34.8% in 2021.

Data source: Provincial cancer agencies and programs

Priority 3 Action 1: Set best practices and standards for care delivery and promote their adoption

Topic: Implementing multidisciplinary care for pediatric cancer patients
Title of image: Percentage of pediatric patients with cancer who were discussed by a multidisciplinary care team case conference prior to treatment
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

85% in 2019 86.3% in 2020

Data source: Provincial cancer agencies and programs

Topic: Implementing multidisciplinary care for pediatric cancer patients
Title of image: Percentage of pediatric patients with cancer who were discussed by a multidisciplinary care team case conference prior to treatment, by sex
Caveats/limitations:

  • Reporting breakdown by sex may be inadvertently misleading. The decision about which pediatric cancer cases are to be discussed by multidisciplinary teams (MDTs) is informed by the patient’s cancer diagnosis, not their sex.
  • The COVID-19 pandemic may have affected service provision.

Male in 2019 was 78.3% and in 2020 was 86.7% Female in 2019 was 94.1% and in 2020 was 85.7%

Data source: Provincial cancer agencies and programs

Topic: Implementing multidisciplinary care for pediatric cancer patients
Title of image: Percentage of pediatric patients with cancer who were discussed by a multidisciplinary care team case conference prior to treatment, by age group
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

In 2019: 0-3 years was 81.8%. 4-6 years was 88.9%. 7-12 years was 80%. 13-16 years was 90%. In 2020: 0-3 years was 80%. 4-6 years was 75%. 7-12 years was 100%. 13-16 years was 92.3%.

Data source: Provincial cancer agencies and programs

Topic: Implementing multidisciplinary care for gastrointestinal (GI) cancer patients
Title of image: Percentage of patients with GI cancer who were discussed by a multidisciplinary care team case conference prior to treatment
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

57.4% in 2019, 58.3% in 2020, and 64% in 2021.

Data source: Provincial cancer agencies and programs

Topic: Implementing multidisciplinary care for gastrointestinal (GI) cancer patients
Title of image: Percentage of patients with GI cancer who were discussed by a multidisciplinary care team case conference prior to treatment, by sex
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

Male: 57.3% in 2019, 52.9% in 2020, and 63.6% in 2021. Female: 57.5% in 2019, 68.5% in 2020, and 64.2% in 2021.

Data source: Provincial cancer agencies and programs

Topic: Implementing multidisciplinary care for gastrointestinal (GI) cancer patients
Title of image: Percentage of patients with GI cancer who were discussed by a multidisciplinary care team case conference prior to treatment, by age group
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

Under 60 years: 58% in 2019, 46.9% in 2020, and 77.1% in 2021. 60 to 69 years: 56.8% in 2019, 70.6% in 2020, and 64.2% in 2021. 70 years and over: 57.1% in 2019, and 57.1% in 2020, and 56.5% in 2021.

Data source: Provincial cancer agencies and programs

Topic: Implementing multidisciplinary care for gastrointestinal (GI) cancer patients
Title of image: Percentage of patients with GI cancer who were discussed by a multidisciplinary care team case conference prior to treatment, by geography
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

Rural and remote: 57.5% in 2019, 56% in 2020, and 61.8% in 2021. Winnipeg: 57.3% in 2019, and 60.5% in 2020, and 65.9% in 2021.

Data source: Provincial cancer agencies and programs

Priority 3 Action 2: Eliminate low-benefit practices and adopt high-value practices

Topic: Optimizing care at end of life
Title of image: Percentage of cancer patients who received their first systemic therapy treatment (i.e., cycle 1 day 1) within the last 15 days of life and who died of cancer-specific causes in 2018-19, overall and by sex

Overall: 1.2%. Male: 1.2%. Female: 1.2%.

Data source: Provincial cancer agencies and programs

Topic: Optimizing care at end of life
Title of image: Percentage of cancer patients who received their first systemic therapy treatment (i.e., cycle 1 day 1) within the last 15 days of life and who died of cancer-specific causes in 2018-19, by age group

19 to 29 years: 0%. 30 to 59 years: 2%. 60 to 69 years: 2.2%. 70 years and over: 0.7%.

 

Data source: Provincial cancer agencies and programs

Topic: Optimizing care at end of life
Title of image: Percentage of cancer patients who received their first systemic therapy treatment (i.e., cycle 1 day 1) within the last 15 days of life and who died from cancer-specific causes in 2018-19, by geography

Rural and remote: 1.2%. Winnipeg: 1.2%

Data source: Provincial cancer agencies and programs

Topic: Optimizing screening and appropriate follow-up
Title of image: Percentage of individuals who received a Pap test who were outside recommended age categories for cervical cancer screening guidelines (18-20 years old or 70 and older)
Caveats/limitations:

  • The COVID-19 pandemic may have affected service provision.
  • >69 years of age may not be inappropriate. Screening should be discontinued at >69 years only if the patient has had 3 negative pap tests in the past 10 years or one negative high-risk HPV test in the last 5 years.

10.5% in 2014-16, and 7.5% in 2017-19.

Data source: Provincial cancer agencies and programs

Topic: Optimizing screening and appropriate follow-up
Title of image: Percentage of individuals aged 21-69 who had two or more screening Pap tests completed within 36 months of the index Pap test (by interval; these individuals have completed specified tests despite having a normal screening result for the index Pap test)
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

8.8% in 2014-16, and 5.7% in 2017-19.

Data source: Provincial cancer agencies and programs

Priority 3 Action 3: Design and implement new models of care

Topic: Expanding models of care
Title of image: Proportion of Pap test specimens tested for high-risk HPV (hrHPV) between 2022-24, overall and by age group

Overall: 2.2%. 30 to 39 years: 2.4%. 40 to 49 years: 2%. 50 to 59 years: 2.7%. 60 to 60 years: 1.8%.

Data source: Provincial cancer agencies and programs

Topic: Expanding models of care
Title of image: Proportion of Pap test specimens tested for hrHPV between 2022-24, by Regional Health Authority

Winnipeg Regional Health Authority: 2.1%. Prairie Mountain Health: 2.1%. Interlake Eastern Regional Health Authority: 2.7%. Southern Health: 2.2%. Northern Regional Health Authority: 4.7%. Unknown: 1.7%.

Data source: Provincial cancer agencies and programs

Priority 4 Action 1: Provide better services and care adapted to the specific needs of underserved groups

Topic: Increasing access to culturally safe care
Title of image: Percentage of respondents to the Ambulatory Oncology Patient Satisfaction Survey who reported a positive response to the question, “Did your care providers treat you with dignity and respect?”
Caveats/limitations:

  • Positive responses were identified as “Yes, completely” or “Yes, somewhat.”
  • The COVID-19 pandemic may have affected service provision.

99.3% in 2021, and 99.5% in 2022.

Data source: Ambulatory Oncology Patient Satisfaction Survey

Topic: Increasing access to culturally safe care
Title of image: Percentage of respondents to the Ambulatory Oncology Patient Satisfaction Survey who reported a positive response to the question, “Did your care providers treat you with dignity and respect?” by sex
Caveats/limitations:

  • Positive responses were identified as “Yes, completely” or “Yes, somewhat.”
  • The COVID-19 pandemic may have affected service provision.

Male: 99.4% in 2021, and 99.6% in 2022. Female: 99.3% in 2021, and 99.5% in 2022.
Data source: Ambulatory Oncology Patient Satisfaction Survey

Topic: Increasing support to help patients navigate the system
Title of image: Percentage of rural/remote Manitobans living with cancer who accessed CancerCare Manitoba’s Navigation Services, by fiscal year
Caveats/limitations:

  • For this indicator, rural/remote is defined as Regional Health Authorities outside of the Winnipeg Regional Health Authority (RHA). This includes Interlake Eastern (RHA), Northern RHA, Prairie Mountain Health, and Southern Health – Santé Sud.
  • The COVID-19 pandemic may have affected service provision.

39.4% in 2019-20, 34.2% in 2020-21, and 40.4% in 2021-22.

Data source: Provincial cancer agencies and programs

Topic: Increasing support to help patients navigate the system
Title of image: Percentage of rural/remote Manitobans living with cancer who accessed CancerCare Manitoba’s Navigation Services in fiscal year 2021-22, by sex
Caveats/limitations:

  • For this indicator, rural/remote is defined as Regional Health Authorities outside of the Winnipeg Regional Health Authority (RHA). This includes Interlake Eastern (RHA), Northern RHA, Prairie Mountain Health, and Southern Health – Santé Sud.
  • The COVID-19 pandemic may have affected service provision.

36.5% for males, and 44.8% for females.

Data source: Provincial cancer agencies and programs

Topic: Increasing support to help patients navigate the system
Title of image: Percentage of rural/remote Manitobans living with cancer who accessed CancerCare Manitoba’s Navigation Services in fiscal year 2021-22, by age
Caveats/limitations:

  • For this indicator, rural/remote is defined as Regional Health Authorities outside of the Winnipeg Regional Health Authority (RHA). This includes Interlake Eastern (RHA), Northern RHA, Prairie Mountain Health, and Southern Health – Santé Sud.
  • The COVID-19 pandemic may have affected service provision.

18 to 30 years: 51.4%. 31 to 40 years: 48%. 41 to 50 years: 41.2%. 51 to 60 years: 37.2%. 61 to 70 years: 38.6%. 71 to 80 years: 43.8%. 81 years and over: 38.3%.

Data source: Provincial cancer agencies and programs

Topic: Increasing support to help patients navigate the system
Title of image: Percentage of rural/remote Manitobans living with cancer who accessed CancerCare Manitoba’s Navigation Services in fiscal year 2021-22, by Regional Health Authority
Caveats/limitations:

  • For this indicator, rural/remote is defined as Regional Health Authorities outside of the Winnipeg Regional Health Authority (RHA). This includes Interlake Eastern (RHA), Northern RHA, Prairie Mountain Health, and Southern Health – Santé Sud.
  • The COVID-19 pandemic may have affected service provision.

Prairie Mountain Health: 44.5%. Interlake Eastern Regional Health Authority: 29.5%. Southern Health: 46.9%. Northern Regional Health Authority: 35.4%.

Data source: Provincial cancer agencies and programs

Priority 4 Action 2: Ensure rural and remote communities have the resources required to better serve their people


Topic: Increasing access to virtual care
Title of image: Percentage of Manitobans newly diagnosed with cancer and living in rural/remote Regional Health Authorities who attended virtual physician visit appointments, by patient and appointment level
Caveats and limitations:

  • Winnipeg was not included as it is not rural.
  • The COVID-19 pandemic may have affected service provision.

Patient Level was 28.4% in 2019 and 73.3% in 2020 Appointment Level was 15.8% in 2019 and 48.2% in 2020
Data source: Provincial cancer agencies and programs

Topic: Increasing access to virtual care
Title of image: Percentage of Manitobans newly diagnosed with cancer and living in rural/remote Regional Health Authorities who attended virtual physician visit appointments, by rural/remote Regional Health Authorities
Caveats and limitations:

  • For this indicator, rural/remote is defined as Regional Health Authorities outside of the Winnipeg Regional Health Authority (RHA). This includes Interlake Eastern (RHA), Northern RHA, Prairie Mountain Health, and Southern Health – Santé Sud. Winnipeg RHA data are not included for this indicator.
  • The COVID-19 pandemic may have affected service provision.

In 2019: Interlake-Eastern Regional Health Authority: 17% Northern Regional Health Authority: 45.2% Prairie Mountain Regional Health Authority: 46.8% Southern Health – Santé Sud Regional Health Authority: 20.4% Unassigned Regional Health Authority: 18.7% In 2020: Interlake-Eastern Regional Health Authority: 69.9% Northern Regional Health Authority: 78.2% Prairie Mountain Regional Health Authority: 77.7% Southern Health – Santé Sud Regional Health Authority: 72% Unassigned Regional Health Authority: 68.8%

Data source: Provincial cancer agencies and programs

Topic: Increasing access to virtual care
Title of image: Percentage of Manitobans newly diagnosed with cancer and living in rural/remote Regional Health Authorities who attended virtual physician visit appointments, by age group
Caveats and limitations:

  • The COVID-19 pandemic may have affected service provision.
  • For this indicator, rural/remote is defined as Regional Health Authorities outside of the Winnipeg Regional Health Authority (RHA). This includes Interlake Eastern (RHA), Northern RHA, Prairie Mountain Health, and Southern Health – Santé Sud. Winnipeg RHA data are not included for this indicator.

In 2019 Less than 20 years: 3.8% 21-30 years: 19.4% 31-40 years: 21.6% 41-50 years: 20.2% 51-60 years: 25.1% 61-70 years: 28.3% 71-80 years: 32.8% 81 years and older: 41.5% In 2020 Less than 20 years: 56.5% 21-30 years: 67.1% 31-40 years: 70.2% 41-50 years: 68% 51-60 years: 70.6% 61-70 years: 75% 71-80 years: 75.1% 81 years and older: 79.5%

Data source: Provincial cancer agencies and programs

Topic: Increasing access to supportive psychosocial care services

Title of image: Percentage of rural and remote cancer patients who were diagnosed with any invasive cancer and indicated willingness to access psychosocial support, by fiscal year

Caveats/limitations:

  • The COVID-19 pandemic may have affected service provision.
  • For this indicator, rural/remote is defined as Regional Health Authorities outside of the Winnipeg Regional Health Authority (RHA). This includes Interlake Eastern (RHA), Northern RHA, Prairie Mountain Health, and Southern Health – Santé Sud. Winnipeg RHA data are not included for this indicator.

7.1% in 2019-20, 3.2% in 2020-21, and 12.8% in 2021-22.

Data source: Provincial cancer agencies and programs

Priority 5 Action 1: Integrate the full spectrum of information and support services to ensure people are fully supported throughout the cancer experience

Topic: Improving availability of information and support
Title of image: Percentage of respondents to the Ambulatory Oncology Patient Satisfaction Survey who reported a positive response to questions related to whether they received enough information across five themes
Caveats/limitations:

  • The COVID-19 pandemic may have affected service provision.
  • The themes reflect positive responses to the following AOPSS questions:
    • Referral: “When you were first told of your illness, were you referred to a care provider who could help you with your anxieties and fears?”
    • Emotions: “Did you get enough information about possible changes in your emotions?”
    • Energy/Fatigue: “Did you get enough information about possible changes in your energy/fatigue level?”
    • Appearance: “Did you get enough information about possible changes to your physical appearance?”
    • Treatment: Were you given enough information about therapies for treating cancer?”

Referral: 35.4% in 2021, and 51% in 2022. Emotions: 73% in 2021, and 73.3% in 2022. Appearance: 88% in 2021, and 86.5% in 2022. Energy and fatigue: 89.5% in 2021, and 87.9 in 2022. Treatment: 96.2% in 2021, and 94.1% in 2022.

Data source: Ambulatory Oncology Patient Satisfaction Survey

Topic: Improving availability of information and support
Title of image: Percentage of male respondents to the Ambulatory Oncology Patient Satisfaction Survey who reported a positive response to questions related to whether they received enough information across five themes
Caveats/limitations:

  • The COVID-19 pandemic may have affected service provision.
  • The themes reflect positive responses to the following AOPSS questions:
    • Referral: “When you were first told of your illness, were you referred to a care provider who could help you with your anxieties and fears?”
    • Emotions: “Did you get enough information about possible changes in your emotions?”
    • Energy/Fatigue: “Did you get enough information about possible changes in your energy/fatigue level?”
    • Appearance: “Did you get enough information about possible changes to your physical appearance?”
    • Treatment: Were you given enough information about therapies for treating cancer?”

Referral: 28.5% in 2021, and 46.4% in 2022. Emotions: 75.1% in 2021, and 74.1% in 2022. Appearance: 88.5% in 2021, and 87% in 2022. Energy and fatigue: 90.2% in 2021, and 87.8% in 2022. Treatment: 97.3% in 2021, and 94.1% in 2022.

Data source: Ambulatory Oncology Patient Satisfaction Survey

Topic: Improving availability of information and support

Title of image: Percentage of female respondents to the Ambulatory Oncology Patient Satisfaction Survey who reported a positive response to questions related to whether they received enough information across five themes

Caveats/limitations:

  • The COVID-19 pandemic may have affected service provision.
  • The themes reflect positive responses to the following AOPSS questions:
    • Referral: “When you were first told of your illness, were you referred to a care provider who could help you with your anxieties and fears?”
    • Emotions: “Did you get enough information about possible changes in your emotions?”
    • Energy/Fatigue: “Did you get enough information about possible changes in your energy/fatigue level?”
    • Appearance: “Did you get enough information about possible changes to your physical appearance?”
    • Treatment: Were you given enough information about therapies for treating cancer?”

Referral: 43.5% in 2021, and 54.9% in 2022. Emotions: 70.6% in 2021, and 72.6% in 2022. Appearance: 87.6% in 2021, and 86.1% in 2022. Energy and fatigue: 88.5% in 2021, and 87.9% in 2022. Treatment: 94.8% in 2021, and 94% in 2022.

Data source: Ambulatory Oncology Patient Satisfaction Survey

Topic: Improving availability of information and support

Title of image: Percentage of respondents to the Ambulatory Oncology Patient Satisfaction Survey who reported a positive response to questions related to whether they received enough information across five themes, by Regional Health Authority

Caveats/limitations:

  • The COVID-19 pandemic may have affected service provision.
  • The themes reflect positive responses to the following AOPSS questions:
    • Referral: “When you were first told of your illness, were you referred to a care provider who could help you with your anxieties and fears?”
    • Emotions: “Did you get enough information about possible changes in your emotions?”
    • Energy/Fatigue: “Did you get enough information about possible changes in your energy/fatigue level?”
    • Appearance: “Did you get enough information about possible changes to your physical appearance?”
    • Treatment: Were you given enough information about therapies for treating cancer?”

See table

Title of table: Percentage of respondents to the Ambulatory Oncology Patient Satisfaction Survey who reported a positive response to questions related to whether they received enough information across five themes, by Regional Health Authority

Regional Health Authority Referral Emotions Appearance Energy/Fatigue Treatment
Winnipeg RHA 50.9% 70.3% 84.9% 87.3% 93.5%
Southern Health-Santé Sud 47.7% 71.3% 83.6% 87.0% 94.4%
Interlake-Eastern RHA 54.3% 75.8% 87.9% 86.0% 93.2%
Prairie Mountain Health 51.7% 79.9% 91.3% 91.5% 95.4%
Northern RHA 51.7% 82.1% 92.5% 86.7% 97.8%

Data source: Ambulatory Oncology Patient Satisfaction Survey

Topic: Improving availability of information and support
Title of image: Percentage of respondents to the Ambulatory Oncology Patient Satisfaction Survey who reported a positive response to questions related to whether they received enough information across five themes, by age group

Caveats/limitations:

  • The COVID-19 pandemic may have affected service provision.
  • The themes reflect positive responses to the following AOPSS questions:
    • Referral: “When you were first told of your illness, were you referred to a care provider who could help you with your anxieties and fears?”
    • Emotions: “Did you get enough information about possible changes in your emotions?”
    • Energy/Fatigue: “Did you get enough information about possible changes in your energy/fatigue level?”
    • Appearance: “Did you get enough information about possible changes to your physical appearance?”
    • Treatment: Were you given enough information about therapies for treating cancer?”

See table

Title of table: Percentage of respondents to the Ambulatory Oncology Patient Satisfaction Survey who reported a positive response to questions related to whether they received enough information across five themes, by age group

Age group Referral Emotions Appearance Energy/Fatigue Treatment
18-34 60.0% 80.0% 100.0% 94.7% 90.0%
35-44 60.4% 79% 90.6% 92.6% 92.4%
45-54 53.0% 73.6% 87.6% 88.5% 92.2%
55-64 53.8% 75.1% 89.6% 91.0% 93.4%
65+ 49.1% 72.2% 84.7% 86.6% 94.6%

Data source: Ambulatory Oncology Patient Satisfaction Survey


Topic: Improving access to shared medical records
Title of image: Percent of healthcare professionals* who currently have direct access to cancer patient information (i.e., are active users) within CancerCare Manitoba’s (CCMB) electronic medical record (ARIA)
Caveats/limitations:

  • The COVID-19 pandemic may have affected service provision.
  • *Here, healthcare professionals include the following seven physician classifications: Family Practitioner, General Practitioner, Physician, Palliative Care Physician, Emergency Medicine Physician, Family Physician in Oncology, and Community Cancer Program Physician.

39.2% in 2019 52.3% in 2020

Data source: Provincial cancer agencies and programs

Priority 5 Action 2: Address the limited and unequal access to palliative and end-of-life care across Canada

Topic: Improving access to quality end-of-life care
Title of image: Cumulative length of stay for cancer patients (overall) who were in or admitted to an acute care hospital 30 days prior to death in Manitoba, by fiscal year

Median: In 2015 was 18 days. In 2017 was 18 days. In 2019 was 18 days. 90th percentile: In 2015 was 60 days. In 2017 was 58 days. In 2019 was 58 days.

Data source: Canadian Institute for Health Information (CIHI), Discharge Abstract Database (DAD)

Topic: Improving access to quality end-of-life care
Title of image: Cumulative length of stay for cancer patients living in rural/remote Regional Health Authorities in Manitoba who were in or admitted to an acute care hospital 30 days prior to death, by fiscal year
Caveats/limitations: For this indicator, rural/remote is defined as Regional Health Authorities outside of the Winnipeg Regional Health Authority (RHA). This includes Interlake Eastern (RHA), Northern RHA, Prairie Mountain Health, and Southern Health – Santé Sud. Winnipeg RHA data are not included for this indicator.

Median: In 2015 was 19 days. In 2017 was 17 days. In 2019 was 18 days. 90th percentile: In 2015 was 66 days. In 2017 was 60 days. In 2019 was 65 days.Data source: Canadian Institute for Health Information (CIHI), Discharge Abstract Database (DAD)

Topic: Improving access to quality end-of-life care
Title of image: Cumulative length of stay for cancer patients living in the single urban Regional Health Authority in Manitoba who were in or admitted to an acute care hospital 30 days prior to death in Manitoba, by fiscal year
Caveats/limitations: For this indicator, urban is defined as the only Winnipeg Regional Health Authority (RHA). This indicator excludes rural/remote RHAs such as Interlake Eastern (RHA), Northern RHA, Prairie Mountain Health, and Southern Health – Santé Sud.

Median: In 2015 was 18 days. In 2017 was 18 days. In 2019 was 18 days. 90th percentile: In 2015 was 58 days. In 2017 was 56 days. In 2019 was 55 days.Data source: Canadian Institute for Health Information (CIHI), Discharge Abstract Database (DAD)

Priority 5 Action 3: Support children, adolescents and young adults at key transition points in their unique cancer journeys

Topic: Improving care for adolescents and young adults with cancer
Title of image: Percentage of AYA with cancer who had a specialized care plan pathway
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

Overall 57.7% By age: 15 to 29 years: 54.5%, 30 to 39 years: 60% By gender: Female: 46.2% Male 69.2% By location: Remote/Rural: 57.1% Urban: 57.9%
Data source: Young Adult Cancer Canada (YACC) Survey 2021


Topic: Improving transitions for adolescents and young adults with cancer
Title of image: Percentage of AYA with cancer who had a positive experience of transition in care along their cancer journey
Caveats/limitations: The COVID-19 pandemic may have affected service provision.

Overall 30.8% Age: 15 to 29 years: 36.4% 30 to 39 years: 26.7% By gender: Female: 23.1% Male 38.5% By location: Remote/Rural: 0% Urban: 42.1%

Data source: Young Adult Cancer Canada (YACC) Survey 2021

The data tables and technical appendix for all indicators are available upon request at info@partnershipagainstcancer.ca. You will receive a response in two to three business days.